2013-01-11
Costs, evidence, and value in the medicare program: The challenges of technology innovation in breast cancer prevention and control
Publication
Publication
JAMA Internal Medicine , Volume 173 - Issue 3 p. 227- 228
Additional Metadata | |
---|---|
doi.org/10.1001/jamainternmed.2013.2127, hdl.handle.net/1765/56563 | |
JAMA Internal Medicine | |
Organisation | Erasmus MC: University Medical Center Rotterdam |
Mandelblatt, J., Tosteson, A., & van Ravesteyn, N. (2013). Costs, evidence, and value in the medicare program: The challenges of technology innovation in breast cancer prevention and control. JAMA Internal Medicine (Vol. 173, pp. 227–228). doi:10.1001/jamainternmed.2013.2127 |